157 related articles for article (PubMed ID: 26885500)
21. Remimazolam attenuates inflammation and kidney fibrosis following folic acid injury.
Song J; Yu W; Chen S; Huang J; Zhou C; Liang H
Eur J Pharmacol; 2024 Mar; 966():176342. PubMed ID: 38290569
[TBL] [Abstract][Full Text] [Related]
22. Anabolic effect of the traditional Chinese medicine compound tanshinone IIA on myotube hypertrophy is mediated by estrogen receptor.
Zhao P; Soukup ST; Hegevoss J; Ngueu S; Kulling SE; Diel P
Planta Med; 2015 May; 81(7):578-85. PubMed ID: 26018796
[TBL] [Abstract][Full Text] [Related]
23. Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles.
Meng Z; Meng L; Wang K; Li J; Cao X; Wu J; Hu Y
Eur J Pharm Sci; 2015 Jun; 73():35-43. PubMed ID: 25769523
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
25. Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo.
Chen J; Shi DY; Liu SL; Zhong L
Oncol Rep; 2012 Feb; 27(2):523-8. PubMed ID: 22038415
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel 11β-HSD1 inhibitor from a high-throughput screen of natural product extracts.
Park SB; Park JS; Jung WH; Park A; Jo SR; Kim HY; Dal Rhee S; Ryu SY; Jeong HG; Park S; Lee H; Kim KY
Pharmacol Res; 2015 Dec; 102():245-53. PubMed ID: 26515507
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory and Apoptotic Regulatory Activity of Tanshinone IIA in Helicobacter pylori-Infected Cells.
Chen GY; Shu YC; Chuang DY; Wang YC
Am J Chin Med; 2016; 44(6):1187-1206. PubMed ID: 27627918
[TBL] [Abstract][Full Text] [Related]
28. Tanshinone IIA attenuates cyclic strain-induced endothelin-1 expression in human umbilical vein endothelial cells.
Hong HJ; Hsu FL; Tsai SC; Lin CH; Liu JC; Chen JJ; Cheng TH; Chan P
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):63-8. PubMed ID: 22032308
[TBL] [Abstract][Full Text] [Related]
29. Renoprotective effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney disease.
Ahn YM; Kim SK; Lee SH; Ahn SY; Kang SW; Chung JH; Kim SD; Lee BC
Phytother Res; 2010 Dec; 24(12):1886-92. PubMed ID: 21043035
[TBL] [Abstract][Full Text] [Related]
30. The Protective Effects and the Involved Mechanisms of Tanshinone IIA on Sepsis-Induced Brain Damage in Mice.
Xiong CQ; Zhou HC; Wu J; Guo NZ
Inflammation; 2019 Feb; 42(1):354-364. PubMed ID: 30255286
[TBL] [Abstract][Full Text] [Related]
31. Prevention of experimental postoperative peritoneal adhesions through the intraperitoneal administration of tanshinone IIA.
Wang C; Li X; Meng X; Zhou J; Qin F; Hou L
Planta Med; 2014 Aug; 80(12):969-73. PubMed ID: 25089738
[TBL] [Abstract][Full Text] [Related]
32. Delayed treatment with PTBA analogs reduces postinjury renal fibrosis after kidney injury.
Skrypnyk NI; Sanker S; Skvarca LB; Novitskaya T; Woods C; Chiba T; Patel K; Goldberg ND; McDermott L; Vinson PN; Calcutt MW; Huryn DM; Vernetti LA; Vogt A; Hukriede NA; de Caestecker MP
Am J Physiol Renal Physiol; 2016 Apr; 310(8):F705-F716. PubMed ID: 26661656
[TBL] [Abstract][Full Text] [Related]
33. Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway.
Zhang XS; Ha S; Wang XL; Shi YL; Duan SS; Li ZA
Neuroscience; 2015 Sep; 303():489-502. PubMed ID: 26116522
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
35. Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts.
Chan P; Liu JC; Lin LJ; Chen PY; Cheng TH; Lin JG; Hong HJ
Am J Chin Med; 2011; 39(2):381-94. PubMed ID: 21476213
[TBL] [Abstract][Full Text] [Related]
36. Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.
Fang J; Xu SW; Wang P; Tang FT; Zhou SG; Gao J; Chen JW; Huang HQ; Liu PQ
Phytomedicine; 2010 Dec; 18(1):58-64. PubMed ID: 20638255
[TBL] [Abstract][Full Text] [Related]
37. Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats.
Wang P; Wu X; Bao Y; Fang J; Zhou S; Gao J; Pi R; Mou YG; Liu P
Pharmazie; 2011 Jul; 66(7):517-24. PubMed ID: 21812327
[TBL] [Abstract][Full Text] [Related]
38. The anti-atherosclerotic effect of tanshinone IIA is associated with the inhibition of TNF-α-induced VCAM-1, ICAM-1 and CX3CL1 expression.
Chang CC; Chu CF; Wang CN; Wu HT; Bi KW; Pang JH; Huang ST
Phytomedicine; 2014 Feb; 21(3):207-16. PubMed ID: 24157079
[TBL] [Abstract][Full Text] [Related]
39. Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways.
Pan C; Lou L; Huo Y; Singh G; Chen M; Zhang D; Wu A; Zhao M; Wang S; Li J
Ther Adv Cardiovasc Dis; 2011 Apr; 5(2):99-111. PubMed ID: 21282198
[TBL] [Abstract][Full Text] [Related]
40. Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway.
Hong HJ; Liu JC; Chen PY; Chen JJ; Chan P; Cheng TH
Int J Cardiol; 2012 May; 157(2):174-9. PubMed ID: 21190747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
